share_log

HC Wainwright & Co. Reiterates Buy on Humacyte, Raises Price Target to $15

HC Wainwright & Co. Reiterates Buy on Humacyte, Raises Price Target to $15

HC Wainwright & Co.重申对Humacyte的买入评级,将目标价提高至15美元
Benzinga ·  12/20 19:48  · 评级/大行评级

HC Wainwright & Co. analyst Vernon Bernardino reiterates Humacyte (NASDAQ:HUMA) with a Buy and raises the price target from $12 to $15.

HC Wainwright & Co. 分析师弗农·贝纳迪诺重申Humacyte(纳斯达克股票代码:HUMA)的买入,并将目标股价从12美元上调至15美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发